-
Genetic testing in oncology
While genetic testing can identify patients who will be nonresponsive to certain drug therapies, it
can also suggest other drugs as treatment options that might work. These may include pharmaceuticals not usually
considered for treatment of a particular cancer. (Source: Drug Topics - Pharmacy News)
-
Low income, minority parents value prevention of cervical cancer by HPV vaccine
Qualitative research performed within a low-income minority community in Boston showed that almost all mothers valued the human papillomavirus (HPV) vaccine and intended to have their daughters vaccinated. Vaccination rate one year later showed that 89% of daughters had received at least one dose of HPV vaccine, which far exceeds the national estimate of 37% coverage in 2008. These parents, one-half of whom were immigrants, frequently had had an abnormal Papanicolaou smear themselves or knew someone with cervical cancer. They also expressed very positive attitudes about the benefit of vaccines to prevent infections, and desire to avoid stigma of sexually transmitted infections. This remarkable experience â although small and in a setting where barriers to access, care, and vaccine availa...
-
Characteristics of papillary thyroid cancer in children and adolescents
Studies of rare diseases, such as papillary thyroid cancer in the pediatric age group, have limitations. Machens et al, however, report a relatively large series of cases and surgical management for 83 consecutive patients with papillary thyroid cancer from a tertiary care surgical referral center in Germany from 1994 through 2009. Findings indicate that children under 12 years of age have similar rates of intra- and extra-thyroid involvement, including high rates of extra-thyroid tumor growth and lymph node metastasis. The authors conclude that surgical management should be as aggressive in younger children as is typical in adolescents, and that expert surgical skills and experience are required to minimize the excessive morbidity attendant to such procedures in small children. (Source: T...
-
Dyskerin and cancer: more than telomerase. The defect in mRNA translation helps in explaining how a proliferative defect leads to cancer
Abstract (Source: The Journal of Pathology)
-
Gynaecological oncology: Implementing the national invasive cervical cancer audit: a local perspective
Please cite this paper as: (Source: BJOG: An International Journal of Obstetrics and Gynaecology)
-
Onyx strikes cancer drug deal in Japan
Onyx Pharmaceuticals Inc. will receive $59 million upfront in a licensing deal with a Japanese company for two experimental cancer-fighting compounds, including the potential blockbuster multiple myeloma drug carfilzomib. (ONXX) (CELG) (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
-
P1.35 Amphiphysin 2 (BIN1) and triad defects in several forms of centronuclear myopathies
Centronuclear myopathies (CNM) are congenital myopathies characterized by generalized muscle weakness and mislocalization of muscle fiber nuclei. Genetically distinct forms exist and mutations in amphiphysin 2 (BIN1) were identified in autosomal recessive cases. BIN1 has been implicated in membrane remodeling in brain and skeletal muscle. We identified novel BIN1 mutations that impact on several functions of this protein. We found that the two BIN1 isoforms expressed in skeletal muscle possess the phosphoinositide-binding domain and are specifically targeted to the triads, close to the DHPRâRYR1 complex. Cardiac isoforms do not contain this domain, suggesting that splicing of BIN1 regulates its specific function in skeletal muscle. Immunohistofluorescence and electron microscopy analysis...
-
Genetic testing in oncology
While genetic testing can identify patients who will be nonresponsive to certain drug therapies, it
can also suggest other drugs as treatment options that might work. These may include pharmaceuticals not usually
considered for treatment of a particular cancer. (Source: Modern Medicine)
-
Finding the tumor copycat: Approximating a human cancer
Nature Medicine 16, 976 (2010). doi:10.1038/nm0910-976
Author: Terry Van Dyke (Source: Nature Medicine)
-
Finding the tumor copycat: Therapy fails, patients don't
Authors: Lee M Ellis & Isaiah J Fidler
The complexity of human metastatic cancer is difficult to mimic in mouse models. As a consequence, seemingly successful studies in murine models do not translate into success in late phases of clinical trials, pouring money, time and people's hope down the drain. In 'Bedside to Bench', Isaiah Fidler and Lee Ellis discuss crucial parameters in cancer growth and therapy and emphasize the disparity between studies in humans and mice. In 'Bench to Bedside', Terry Van Dyke shows how pancreatic tumors developed de novo in the organ site in mice can explain therapy failure in people with cancer and serve as a model to test new drugs. (Source: Nature Medicine)
-
A cancer fate in the hands of a samurai
Nature Medicine 16, 963 (2010). doi:10.1038/nm0910-963
Author: Malcolm A S Moore
Recent studies show that Musashi-2 (MSI2), a molecule that binds RNA, increases proliferation of normal and malignant blood stem cells. In humans, increased amounts of MSI2 correlate with poor prognosis of leukemia—indicating that MSI2 may be a target to treat this type of cancer. (Source: Nature Medicine)
-
5 Things Not To Say To Quitting Smokers
Smoking causes cancer, emphysema, and all sorts of other problems. But smokers have heard these arguments so often that they're like the annoying buzz of a mosquito. (Source: WDSU.com - Health)
-
Genetic testing in oncology
While genetic testing can identify patients who will be nonresponsive to certain drug therapies, it
can also suggest other drugs as treatment options that might work. These may include pharmaceuticals not usually
considered for treatment of a particular cancer. (Source: Drug Topics - Clinical News)
-
Magic mushrooms "may treat cancer"
Scientists in the US have claimed the lives of patients with advanced cancer may be improved by a mind-altering "magic mushroom" drug (Source: Pharmacy Europe)
-
Genetic testing in oncology
While genetic testing can identify patients who will be nonresponsive to certain drug therapies, it
can also suggest other drugs as treatment options that might work. These may include pharmaceuticals not usually
considered for treatment of a particular cancer. (Source: Drug Topics - Top News)
-
Comparative evaluation of NBUVB phototherapy and PUVA photochemotherapy in chronic plaque psoriasis
Conclusion: We concluded that PUVA group patients achieved a faster clearance, but the adverse effects were significantly lower in the NBUVB group. (Source: Indian Journal of Dermatology, Venereology and Leprology)
-
Editorial Board
(Source: Cancer Treatment Reviews)
-
The novel histone deacetylase inhibitor, ARâ42, inhibits gp130/STAT3 pathway and induces apoptosis and cell cycle arrest in multiple myeloma cells
Abstract (Source: International Journal of Cancer)
-
Cell typeâdependent biomarker expression in adenoid cystic carcinoma
Abstract (Source: Cancer)
-
Pros, cons converting to electronic medical records
The Department of Health and Human Services recently released rules for creating electronic health records. These rules came days after HHS issued regulations to safeguard the privacy of medical records. (Source: Cancer Network)
-
Mexican origin: Breast cancer comes early
HOUSTON, Sept. 7 (UPI) -- U.S. researchers say screening for breast cancer needs to begin sooner for women of Mexican-ancestry than for other women.
Breast cancer - Cancer - Health - Breast - United States (Source: Health News - UPI.com)
-
Ethics 101: Health Charities Must Safeguard Patient Data
Some non-profit organizations need to clean up their act and the public can help.09/15/2010 (Source: Kidney Cancer Association)
-
STAND UP TO CANCER TEAMS UP WITH eBay GIVING WORKS FOR SPECIAL ONLINE CHARITY AUCTION
Bid on One of A Kind Experiences and Celebrity Meet and Greets in Movies, Music, TV, Radio, Sports & Broadway!Â
read more (Source: Stand Up 2 Cancer)
-
Pancreatic Chemo Comparison Finds No Survival Boost
Search for more successful treatments for the deadly cancer continues, expert says (Source: Cancercompass News: Other Cancer)
-
Surgical outcomes of borderline breast lesions detected by needle biopsy in a breast screening program
Conclusions:
Further research is required to determine whether characteristics of the mammographic lesion (particularly calcification patterns), the area targeted for biopsy and number of core samples retrieved, can indicate a closer correlation with eventual pathology. This study identified no findings in the diagnostic assessment that could exclude women with borderline lesions from surgical biopsy. (Source: World Journal of Surgical Oncology)
-
CT tests in pregnancy don't raise kids' cancer risk
CT scans and other nuclear medicine diagnostic tests during a woman's pregnancy do not increase her baby's risk of cancer, new data suggest. (Source: CBC | Health)
-
Serum HGF Predicts NSCLC Response to EGFR Tyrosine Kinase Inhibitors
Low pretreatment serum hepatocyte growth factor (HGF) levels predict a better response to EGFR tyrosine kinase inhibitors (TKIs) in patients with non-small-cell lung cancer (NSCLC), researchers from Japan report in the August 2nd Clinical Cancer Research online. Reuters Health Information (Source: Medscape Medical News Headlines)
-
Pancreatic Chemo Comparison Finds No Survival Boost
Search for more successful treatments for the deadly cancer continues, expert says (Source: Pharmacy News - Doctors Lounge)
-
Effects of Prostate-Specific Antigen Testing on Familial Prostate Cancer Risk Estimates
Conclusions
Increased diagnostic activity among men with a family history of prostate cancer appears to contribute to their increased risk of prostate cancer and to lead to detection bias in epidemiological and genetic studies of familial prostate cancer. (Source: JNCI)
-
Early Breast Cancer: Single Dose of Radiation During Surgery Gains Support
(Source: JNCI)
-
A National Cancer Clinical Trials System for the 21st Century: Reinvigorating the NCI Cooperative Group Program
(Source: JNCI)
-
MicroRNAs As Onco-miRs, Drivers of Cancer
(Source: JNCI)
-
Lung Cancer Cell Lines as Tools for Biomedical Discovery and Research
Lung cancer cell lines have made a substantial contribution to lung cancer translational research and biomedical discovery. A systematic approach to initiating and characterizing cell lines from small cell and non–small cell lung carcinomas has led to the current collection of more than 200 lung cancer cell lines, a number that exceeds those for other common epithelial cancers combined. The ready availability and widespread dissemination of the lines to investigators worldwide have resulted in more than 9000 citations, including multiple examples of important biomedical discoveries. The high (but not perfect) genomic similarities between lung cancer cell lines and the lung tumor type from which they were derived provide evidence of the relevance of their use. However, major problems ...
-
Promoter Polymorphisms and Transcript Levels of Nicotinic Receptor CHRNA5
Chromosomal locus 15q25, implicated in lung cancer risk and nicotine dependence, shows extensive linkage disequilibrium that complicates identification of causal variation. Cholinergic receptor nicotinic 5 (CHRNA5) has been identified as a lung cancer risk factor. We identified by sequence analysis three haplotypes (delTTC, insATC, and insTGG) in the 5' promoter region and three at the 3'-untranslated region of CHRNA5. Linkage disequilibrium analysis of the 5' variants showed that the insTGG haplotype is associated with three tightly linked risk alleles (nicotine dependence, lung cancer, and chronic obstructive pulmonary disease). The three CHRNA5 promoter haplotypes were statistically significantly associated with lung CHRNA5 transcript levels, determined by real-time polymerase chain rea...
-
Overexpression and Activation of the {alpha}9-Nicotinic Receptor During Tumorigenesis in Human Breast Epithelial Cells
Conclusion
The 9-nAChR is important for nicotine-induced transformation of normal human breast epithelial cells. (Source: JNCI)
-
Re: Population-Based Study of Contralateral Prophylactic Mastectomy and Survival Outcomes of Breast Cancer Patients
(Source: JNCI)
-
Response: Re: Population-Based Study of Contralateral Prophylactic Mastectomy and Survival Outcomes of Breast Cancer Patients
(Source: JNCI)
-
Brothers of Prostate Cancer Patients Undergo More Diagnostic Activities
(Source: JNCI)
-
Nicotine Binding to Receptor Linked to Breast Cancer Cell Growth
(Source: JNCI)
-
From Nicotine to Breast Cancer, Implications of Cholinergic Receptor Pathway
(Source: JNCI)
-
Prostate-Specific Antigen, Risk Factors, and Prostate Cancer: Confounders Nestled in an Enigma
(Source: JNCI)
-
"Moving Swiftly On." Psychological Support Provided by District Nurses to Patients With Palliative Care Needs
UK district nurses conduct early support visits with palliative patients and this article describes how patients perceive the visits Cancer Nursing (Source: Medscape Hematology-Oncology Headlines)
-
Refinement of Adjuvant Therapy for Pancreatic Cancer [Editorial]
(Source: JAMA)
-
Adjuvant Chemotherapy With Fluorouracil Plus Folinic Acid vs Gemcitabine Following Pancreatic Cancer Resection: A Randomized Controlled Trial [Original Contribution]
Conclusion Compared with the use of fluorouracil plus folinic acid, gemcitabine did not result in improved overall survival in patients with completely resected pancreatic cancer.
Trial Registration clinicaltrials.gov Identifier: NCT00058201 (Source: JAMA)
-
Pancreatic Cancer [JAMA Patient Page]
(Source: JAMA)
-
Vitamins' impact on colon cancer minimal: study
Taking multivitamins for colon cancer during and after surgery and chemotherapy does not significantly reduce the risk of recurrence or extend survival, a new study finds. (Source: CBC | Health)
-
Health Buzz: 'Magic Mushrooms' May Ease End-of-Life Anxiety in Cancer Patients
Preventing hereditary cancers with surgery; what you should know about the future of retirement. (Source: U.S. News - Health)
-
8 Cancer Red Flags Your Doc Should Never Ignore
Do You Know What to Look For? You Should (Source: Health News: CBSNews.com)
-
Redox Biology: NADPH Oxidases, Imaging
For more information, visit
http://ccr.cancer.gov/careers/courses/rb/Air date: 11/9/2010 4:00:00 PM (Source: Videocast - All Events)
-
Redox Biology: Carcinogenesis and Epidemiology
For more information, visit
http://ccr.cancer.gov/careers/courses/rb/Air date: 11/2/2010 4:00:00 PM (Source: Videocast - All Events)
-
Redox Biology: Signal Transduction and Inflammation
For more information, visit
http://ccr.cancer.gov/careers/courses/rb/Air date: 10/26/2010 4:00:00 PM (Source: Videocast - All Events)
-
Redox Biology: Angiogenesis and Cancer Therapy
For more information, visit
http://ccr.cancer.gov/careers/courses/rb/Air date: 10/19/2010 4:00:00 PM (Source: Videocast - All Events)
-
TRACO: Colorectal Cancer and Case Report
For more information, visit
http://ccr.cancer.gov/careers/traco.aspAir date: 12/21/2010 4:00:00 PM (Source: Videocast - All Events)
-
TRACO: Stem Cells and Nanotechnology
For more information, visit
http://ccr.cancer.gov/careers/traco.aspAir date: 12/13/2010 4:00:00 PM (Source: Videocast - All Events)
-
TRACO: Vaccines and Inflammation
For more information, visit
http://ccr.cancer.gov/careers/traco.aspAir date: 12/6/2010 4:00:00 PM (Source: Videocast - All Events)
-
TRACO: Vaccines and Inflammation
For more information, visit
http://ccr.cancer.gov/careers/traco.aspAir date: 12/6/2010 4:00:00 PM (Source: Videocast - All Events)
-
TRACO: Cervical Cancer and Ovarian Cancer
For more information, visit
http://ccr.cancer.gov/careers/traco.aspAir date: 11/29/2010 4:00:00 PM (Source: Videocast - All Events)
-
TRACO: Breast Cancer and Epigenetics
For more information, visit
http://ccr.cancer.gov/careers/traco.aspAir date: 11/22/2010 4:00:00 PM (Source: Videocast - All Events)
-
TRACO: RNAi and Lung Cancer
RNAi and lung cancer
For more information, visit
http://ccr.cancer.gov/careers/traco.aspAir date: 11/15/2010 4:00:00 PM (Source: Videocast - All Events)
-
TRACO: Epidemiology
For more information, visit
http://ccr.cancer.gov/careers/traco.aspAir date: 11/8/2010 4:00:00 PM (Source: Videocast - All Events)
-
TRACO: Angiogenesis and Genomics
For more information, visit
http://ccr.cancer.gov/careers/traco.aspAir date: 11/1/2010 4:00:00 PM (Source: Videocast - All Events)
-
TRACO: HIV and Imaging
For more information, visit
http://ccr.cancer.gov/careers/traco.aspAir date: 10/28/2010 4:00:00 PM (Source: Videocast - All Events)
-
âMagic Mushroomâ Hallucinogen Might Help Cancer Patients
Study found it eased anxieties, lifted spirits in those with advanced disease (Source: Pharmacy News - Doctors Lounge)
-
TRACO: Prostate Cancer and Radiation Oncology
For more information, visit
http://ccr.cancer.gov/careers/traco.aspAir date: 10/25/2010 4:00:00 PM (Source: Videocast - All Events)
-
Redox Biology: Redox Biology and Enzymes
For more information, visit
http://ccr.cancer.gov/careers/courses/rb/Air date: 10/5/2010 4:00:00 PM (Source: Videocast - All Events)
-
Redox Biology: Introduction and Redox chemistry
For more information, visit
http://ccr.cancer.gov/careers/courses/rb/Air date: 9/28/2010 4:00:00 PM (Source: Videocast - All Events)
-
TRACO: Metastasis and Health Disparities
For more information, visit
http://ccr.cancer.gov/careers/traco.aspAir date: 9/27/2010 4:00:00 PM (Source: Videocast - All Events)
-
TRACO: Clinical Trials and Small Molecule Inhibitors
For more information, visit
http://ccr.cancer.gov/careers/traco.aspAir date: 9/20/2010 4:00:00 PM (Source: Videocast - All Events)
-
TRACO: Introduction, Lung cancer tyrosin kinase inhibitors
For more information, visit
http://ccr.cancer.gov/careers/traco.aspAir date: 9/14/2010 4:00:00 PM (Source: Videocast - All Events)
-
'Magic Mushroom' Hallucinogen Might Help Cancer Patients
Study found it eased anxieties, lifted spirits in those with advanced disease (Source: U.S. News - Health)
-
A Wide-Open Door to Corporate Influence
Despite concerns from the not-for-profit community, the International Kidney Cancer Coalition continues to slide down a slippery slope with its funding practices
By Paula Bowen and Bill Bro
Last spring, we expressed concern about a newly proposed organization in the kidney cancer community, sponsored by at least three large pharmaceutical companies that sought to consolidate the activities of many kidney cancer not-for-profits into one “super organization.”
We questioned the wisdom of this proposal, which had none of the usual ethical safeguards and firewalls that are applied when industry provides monetary support for not-for-profits: No transparency, no disclosure of funding, no protections against corporate bias or influence.
When our organization, the Kidney Cancer Asso...
-
Brentwood lab DiaTech Oncology filed for patent on cancer fighting method
A Brentwood laboratory that helps physicians diagnose and treat cancer says it has developed a new method for validating drugs that could shorten development time. (Source: bizjournals.com Health Care:Physician Practices headlines)
-
First AXL1717 Clinical Data From Ongoing Phase I/II Study in Cancer Patients has Been Published
STOCKHOLM, September 7, 2010 /PRNewswire/ -- Axelar AB today
announces that the first submitted medical article on the ongoing
phase I/II cancer study with AXL1717 has been published in Acta
Oncologica.
The article, including clinical data from... (Source: Drugs.com - Clinical Trials)
-
Scancell Holdings Plc (?Scancell Holdings' or the ?Company') Collaboration With ImmuneRegen BioSciences® Yields Positive Results in Cancer Vaccine Studies
NOTTINGHAM, England--(BUSINESS WIRE)--Sep 7, 2010 - Scancell
Holdings Plc, (AIM: SCLP), the developer of therapeutic cancer
vaccines, announces that a treatment utilising a DNA vaccine based
on its ImmunoBody® technology, in combination with... (Source: Drugs.com - Clinical Trials)
-
Low Carb Plant Sourced Diet Better Than Animal Sourced One
If you want to live longer, you are better off on a low carb diet which is vegetable based, rather than one whose proteins are sourced from animals, according to a study involving 129,716 men and women published this week in the medical journal Annals of Internal Medicine. The researchers found lower overall mortality rates and lower death rates from cancer and cardiovascular disease among the low carb veggie people... (Source: Health News from Medical News Today)
-
Immutep announces final results in phase I/II chemoimmunotherapy trial in metastatic breast cancer
Clinical research paper describes IMP321âs potency in
achieving clinical benefit in 90 per cent of patients, combined
with paclitaxel in first-line metastatic breast cancer
Orsay, France, September 7, 2010 - Immutep S.A. announced today
the... (Source: Drugs.com - Clinical Trials)
-
Surgery or Chemo First in Advanced Ovarian Cancer? New Data Fuel Debate
New data suggest equivalence, but an American expert has concerns about the study. Medscape Medical News (Source: Medscape Today Headlines)
-
Oral bisphosphonates associated with increased risk for esophageal cancer
Green J. BMJ. 2010;doi:10.1136/bmj.c4444 (Source: HemOncToday.com)
-
Magic mushrooms may ease anxiety of cancer: study
CHICAGO (Reuters) - The hallucinogen psilocybin -- known by the street name magic mushrooms -- may help ease the anxiety that often accompanies late-stage cancer, U.S. researchers said on Monday. (Source: Reuters: Health)
-
Study: Some Low-Carb Diets Up Cancer, Death Risk
Plans Based on Animal Protein Found Wanting; Veggie-Based Ones May Lower Heart Disease, Death Rates, the Research Shows (Source: Health News: CBSNews.com)
-
PSA test drives diagnosis within families
The brothers of men with prostate cancer face a higher disease risk because of increased diagnostic activity, and not necessarily because they carry a genetic mutation that increases risk of the disease, according to a Swedish study. (Source: Cancer Network)
-
NHS Choices: Six Warning Signs Of Cancer
More than 1/3 people in the UK will develop some form of cancer during their lifetime. The good news is that some cancers can be cured if detected early enough. The key is to be aware of unexplained changes to your body, and to know the common signs and symptoms of cancer. While many cancer symptoms are common of other illnesses and usually nothing to worry about, you should see your GP if you have any of the below warning signs. This is so your GP can check your symptoms and either rule out cancer, or get you treated immediately... (Source: Health News from Medical News Today)
-
Ghostwritten articles overstated benefits of HRT
(Source: BMJ Online First)
-
Gaps persist in cancer survival
Despite significant improvements in cancer survival rates across England, regional differences remain, national statistics show. (Source: BBC News | Health | UK Edition)
-
Immutep Announces Final Results In Phase I/II Chemoimmunotherapy Trial In Metastatic Breast Cancer
Immutep S.A. announced the publication of a clinical research paper showing that its lead product, IMP321, given with first-line paclitaxel achieved clinical benefit in 90 per cent of metastatic breast carcinoma (MBC) patients. Correlations were observed with both the patients' monocyte (i.e. the primary target cell for IMP321) count before treatment and the degree of activation of monocytes during treatment. The study was an open-label fixed-dose-escalation trial carried out in three cancer centers in the Paris region. The lead center was the René Huguenin Cancer Centre in Saint Cloud... (Source: Health News from Medical News Today)
-
Addition of Sutent to Tarceva Does Not Prolong Survival
Sutent is an oral targeted agent that works by inhibiting multiple biologic pathways involved in the growth, replication, and spread of cancer cells. It has been shown to be effective in the treatment of selected patients with kidney cancer or gastrointestinal stromal tumors, and is also being evaluated in the treatment of other types of cancer.09/07/2010 (Source: Kidney Cancer Association)
-
Secondary Malignancies Following Radiotherapy for Prostate Cancer
What risk does radiotherapy pose to prostate cancer patients? Therapeutic Advances in Urology (Source: Medscape Today Headlines)
-
Metronomic Chemotherapy: New Rationale for New Directions
The latest clinical trials of metronomic chemotherapy in adult and pediatric cancer patients are discussed and the authors highlight the research efforts that need to be made to facilitate the optimal development of metronomic chemotherapy in the clinic. Nature Reviews Clinical Oncology (Source: Medscape Today Headlines)
-
Researchers Battle 'Triple Negative' Cancer
Scientists are taking aim at an particularly devastating type of cancer known as "triple negative" breast cancer. (Source: WDSU.com - Health)
-
Like Michael Douglas, I drank and smoked but never dreamt I'd get throat cancer
When Keith Hern saw the pictures of Hollywood actor Michael Douglas looking gaunt following his throat cancer diagnosis, the painful memories of his own battle with the disease flooded back. (Source: the Mail online | Health)
-
'Genetic link' to breast cancer
Researchers have identified a series of genetic variations which may play a role in a common breast cancer. (Source: BBC News | Health | UK Edition)
-
Hallucinogen Found To Safely Ease Anxiety In Advanced-Stage Cancer Patients
In the first human study of its kind to be published in more than 35 years, researchers found psilocybin, an hallucinogen which occurs naturally in "magic mushrooms," can safely improve the moods of patients with advanced-stage cancer and anxiety, according to an article published online in the Archives of General Psychiatry... (Source: Health News from Medical News Today)
-
Poor Public Awareness Highlights Radiotherapy's 'Cinderella' Status
Only one in ten people know that radiotherapy helps cure forty per cent of cancer patients according to new figures* published by Cancer Research UK today (Tuesday). The survey of more than 2,000 people from across the UK also reveals just 14 per cent are aware that half of all cancer patients could benefit from radiotherapy as part of their treatment. Cancer Research UK believes lack of public awareness about radiotherapy's importance in treating cancer is having a serious impact on providing world class treatment for the UK... (Source: Health News from Medical News Today)
-
Preventative mastectomies can reduce risk
SAN ANTONIO, Sept. 7 (UPI) -- Preventative mastectomies do reduce cancer risks for some women, U.S. researchers say.
Cancer - Health - Conditions and Diseases - Breast cancer - Mastectomy (Source: Health News - UPI.com)
-
Losing weight may pollute the blood
Weight loss releases chemical pollutants into the blood, which can stick around, increasing the risk of diabetes, cancer and dementia (Source: New Scientist - Health)
-
Hallucinogen can safely ease anxiety in advanced-stage cancer patients, study suggests
In the first human study of its kind to be published in more than 35 years, researchers found psilocybin, an hallucinogen which occurs naturally in "magic mushrooms," can safely improve the moods of patients with advanced-stage cancer and anxiety. (Source: ScienceDaily Headlines)
-
Brazil to increase access to cancer treatments
(Source: PharmacoEconomics and Outcomes News)
-
New Treatment Activates Death Program In Cancer Cells
Cancer is a difficult disease to treat because it's a personal disease. Each case is unique and based on a combination of environmental and genetic factors. Conventional chemotherapy employs treatment with one or more drugs, assuming that these medicines are able to both "diagnose" and "treat" the affected cells. Many of the side effects experienced by chemotherapy patients are due to the fact that the drugs they are taking aren't selective enough... (Source: Health News from Medical News Today)
-
Blocking HMGB1 May Benefit Cancer Patients
Like some people, cells eat when they are under pressure - but they consume parts of themselves. A multi-function protein helps control this form of cannibalism, according to a study in the September 6 issue of the Journal of Cell Biology. Cells often respond to hunger or stress by digesting some of their contents. The process, known as autophagy, helps free nutrients and clean up cytoplasmic trash such as worn-out organelles and misshapen proteins... (Source: Health News from Medical News Today)
-
Surgeon receives $1.5 million grant to study colon cancer
Emina Huang, M.D., an associate professor of surgery in the College of Medicine, has received a $1.52 million grant from the National Institutes of Health to fund her research into the origins of colon cancer.
The five-year grant will allow Huang to... (Source: OrlandoSentinel: Medical Research)
|
